BSF Enterprise
London
About BSF Enterprise
BSF Enterprise (LON:BSFA) is unlocking the next generation of biotech solutions through an acquisition-led growth strategy to drive the development of lab-grown tissues. Cell-based tissue engineering can be used to generate cultured meat, lab-grown leather, human corneas, collagen growth and skin substitutes. This technology will contribute to a radical transformation of the delivery of sustainable solutions across a variety of sectors.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $20.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Dec 2025)
- Ticker: lse:BSFA
- Website: bsfenterprise.com
- Phone: 442032834590
Industries & Categories
Alternative Protein, Biotechnology, Marketing
Social Profiles
Canonical: https://fsome.com/organization/bsf-enterprise-50227 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.